✦ LIBER ✦

Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors

✍ Scribed by M. Moegele; S. Buchholz; S. Seitz; Olaf Ortmann

Book ID: 113039750
Publisher: Springer
Year: 2012
Tongue: English
Weight: 257 KB
Volume: 285
Category: Article
ISSN: 0003-9128
DOI: 10.1007/s00404-011-2181-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aromatase Inhibitors as Adjuvant Therapy

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

✍ Dr. Ragini Kudachadkar; Dr. Ruth M. O'Regan 📂 Article 📅 2005 🏛 American Cancer Society 🌐 English ⚖ 692 KB

Aromatase Inhibitors as Solely Treatment

Aromatase Inhibitors as Solely Treatment in Postmenopausal Breast Cancer Patients

✍ Ursula Hille; Philipp Soergel; Florian Länger; Cordula Schippert; Lars Makowski; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Aromatase inhibitors as adjuvant therapi

Aromatase inhibitors as adjuvant therapies in patients with breast cancer

✍ R.Charles Coombes; L Gibson; E Hall; M Emson; J Bliss 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Role of aromatase inhibitors in the upfr

Role of aromatase inhibitors in the upfront adjuvant hormonal therapy of postmenopausal patients with breast cancer

✍ Jean-Marc Nabholtz; Marie-Ange Mouret-Reynier; Xavier Durando; Isabelle Van Praa 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 152 KB

Switching from tamoxifen to aromatase in

Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer

✍ C.J.H. van de Velde; S. Verma; J.G.H. van Nes; C. Masterman; K.I. Pritchard 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Use of aromatase inhibitors in postmenop

Use of aromatase inhibitors in postmenopausal women with advanced breast cancer

✍ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast